A benchmark data set for model-based glycemic control in critical care

Journal of Diabetes Science and Technology

Volumn 2, Issue 4, 2008, Pages 584-594

  Chase, J Geoffrey ^a   Lecompte, Aaron ^a   Shaw, Geoffrey M ^b   Blakemore, Amy ^a   Wong, Jason ^a   Lin, Jessica ^b   Hann, Christopher E ^a  

^a UNIVERSITY OF CANTERBURY   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Clinical results; Control; Critical care; Glucose variability; Hyperglycemia; Model based; Mortality

Indexed keywords

EID: 77951693336     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229680800200409     Document Type: Article

References (62)

1. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000;355(9206):773-8.
2. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345(19):1359-67.
3. Mizock BA. Alterations in fuel metabolism in critical illness: hyperglycaemia. Best Pract Res Clin Endocrinol Metab. 2001;15(4):533-51.
4. McCowen KC, Malhotra A, Bistrian BR. Stress-induced hyperglycemia. Crit Care Clin. 2001;17(1):107-24.
5. Patino JF, de Pimiento SE, Vergara A, Savino P, Rodriguez M, Escallon J. Hypocaloric support in the critically ill. World J Surg. 1999;23(6):553-9.
6. Weissman C. Nutrition in the intensive care unit. Crit Care. 1999;3(5):R67-75.
7. Woolfson AM. Control of blood glucose during nutritional support in ill patients. Intensive Care Med. 1980;7(1):11-14.
8. Ahrens CL, Barletta JF, Kanji S, Tyburski JG, Wilson RF, Janisse JJ, Devlin JW. Effect of low-calorie parenteral nutrition on the incidence and severity of hyperglycemia in surgical patients: a randomized, controlled trial. Crit Care Med. 2005;33(11):2507-12.
9. Kim H, Son E, Kim J, Choi K, Kim C, Shin W, Suh O. Association of hyperglycemia and markers of hepatic dysfunction with dextrose infusion rates in Korean patients receiving total parenteral nutrition. Am J Health Syst Pharm. 2003;60(17):1760-6.
10. Krishnan JA, Parce PB, Martinez A, Diette GB, Brower RG. Caloric intake in medical ICU patients: consistency of care with guidelines and relationship to clinical outcomes. Chest. 2003;124(1):297-305.
11. Bistrian BR. Hyperglycemia and infection: which is the chicken and which is the egg? JPEN J Parenter Enteral Nutr. 2001;25(4):180-1.
12. Marik PE, Raghavan M. Stress-hyperglycemia, insulin and immunomodulation in sepsis. Intensive Care Med. 2004;30(5):748-56.
13. Diringer MN. Improved outcome with aggressive treatment of hyperglycemia: hype or hope? Neurology. 2005;64(8):1330-1.
14. Krinsley JS. Decreased mortality of critically ill patients with the use of an intensive glycemic management protocol. Crit Care Med. 2003;31:A19.
15. Krinsley JS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc. 2004;79(8):992-1000.
16. Van den Berghe G, Wouters PJ, Bouillon R, Weekers F, Verwaest C, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P. Outcome beneft of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med. 2003;31(2):359-66.
17. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354(5):449-61.
18. Krinsley JS, Jones RL. Cost analysis of intensive glycemic control in critically ill adult patients. Chest. 2006;129(3):644-50.
19. Van den Berghe G, Wouters PJ, Kesteloot K, Hilleman DE. Analysis of healthcare resource utilization with intensive insulin therapy in critically ill patients. Crit Care Med. 2006;34(3):612-616.
20. Goldberg PA, Siegel MD, Sherwin RS, Halickman JI, Lee M, Bailey VA, Lee SL, Dziura JD, Inzucchi SE. Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. Diabetes Care. 2004;27(2):461-7.
21. Laver S, Preston S, Turner D, McKinstry C, Padkin A. Implementing intensive insulin therapy: development and audit of the Bath insulin protocol. Anaesth Intensive Care. 2004;32(3):311-6.
22. Thomas AN, Marchant AE, Ogden MC, Collin S. Implementation of a tight glycaemic control protocol using a web-based insulin dose calculator. Anaesthesia. 2005;60(11):1093-1100.
23. Meijering S, Corstjens AM, Tulleken JE, Meertens JH, Zijlstra JG, Ligtenberg JJ. Towards a feasible algorithm for tight glycaemic control in critically ill patients: a systematic review of the literature. Crit Care. 2006;10(1):R19.
24. Goldberg PA, Sakharova OV, Barrett PW, Falko LN, Roussel mg, Bak L, Blake-Holmes D, Marieb NJ, Inzucchi SE. Improving glycemic control in the cardiothoracic intensive care unit: clinical experience in two hospital settings. J Cardiothorac Vasc Anesth. 2004;18(6):690-697.
25. Shulman R, Finney SJ, O'Sullivan C, Glynne PA, Greene R. Tight glycaemic control: a prospective observational study of a computerised decision-supported intensive insulin therapy protocol. Criti Care. 2007;11(4):R75.
26. Lonergan T, Le Compte A, Willacy M, Chase JG, Shaw GM, Wong XW, Lotz T, Lin J, Hann CE. A simple insulin-nutrition protocol for tight glycemic control in critical illness: development and protocol comparison. Diabetes Technol Ther. 2006;8(2):191-206.
27. Wong XW, Chase JG, Shaw GM, Hann CE, Lin J, Lotz T. Comparison of adaptive and sliding-scale glycaemic control in critical care and the impact of nutritional inputs. Proc of the 12th International Conf on Biomedical Engineering (ICBME 2005); 2005 Dec. 7-10; Singapore; 2005.
28. Chee F, Fernando T, van Heerden PV. Closed-loop control of blood glucose levels in critically ill patients. Anaesth Intensive Care. 2002;30(3):295-307.
29. Chase JG, Lonergan T, Le Compte A, Willacy M, Shaw GM, Wong XW, Lin J, Lotz T, Hann CE. Tight glucose control in critically ill patients using a specialized insulin-nutrition table. Proc of the 12th International Conf on Biomedical Engineering (ICBME 2005); 2005 Dec. 7-10; Singapore; 2005.
30. Queale WS, Seidler AJ, Brancati FL. Glycemic control and sliding scale insulin use in medical inpatients with diabetes mellitus. Arch Intern Med. 1997;157(5):545-52.
31. Kletter GG. Sliding scale fallacy. Arch Intern Med. 1998;158(13):1472.
32. Radack HB. Sliding scale insulin use. Arch Intern Med. 1997;157(15):1776.
33. Sawin CT. Action without beneft. The sliding scale of insulin use. Arch Intern Med. 1997;157(5):489.
34. Gale SC, Gracias VH. Glycemic control needs a standard reference point. Crit Care Med. 2006;34(6):1856-7.
35. Mackenzie I, Ingle S, Zaidi S, Buczaski S. Tight glycaemic control: a survey of intensive care practice in large English hospitals. Intensive Care Med. 2005;31(8):1136.
36. Schultz MJ, Spronk PE, Moeniralam HS. Tight glycaemic control: a survey of intensive care practice in the Netherlands. Intensive Care Med. 2006;32(4):618-9.
37. Chase JG, Hann CE, Shaw GM, Wong XW, Lin J, Lotz T, Le Compte AJ, Lonergan T. An overview of glycemic control in critical care: relating performance and clinical results. J Diabetes Sci Technol. 2007;1(1):82-91.
38. Egi M, Bellomo R, Stachowski E, French CJ, Hart G. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology. 2006;105(2):244-52.
39. Chase JG, Shaw GM, Lin J, Doran CV, Hann C, Lotz T, Wake GC, Broughton B. Targeted glycemic reduction in critical care using closed-loop control. Diabetes Technol Ther. 2005;7(2):274-82.
40. Chee F, Fernando TL, Savkin AV, van Heeden V. Expert PID control system for blood glucose control in critically ill patients. IEEE Trans Inf Technol Biomed. 2003;7(4):419-25.
41. Blaha J, Hovorka R, Matias M, Kotulak T, Kremen J, Sloukova A, Svacina S, Haluzik M. Intensive insulin therapy in critically ill patients: comparison of standard and MPC protocols. Intensive Care Med. 2005;31(S1):S203.
42. Plank J, Blaha J, Cordingley J, Wilinska ME, Chassin LJ, Morgan C, Squire S, Haluzik M, Kremen J, Svacina S, Toller W, Plasnik A, Ellmerer M, Hovorka R, Pieber TR. Multicentric, randomized, controlled trial to evaluate blood glucose control by the model predictive control algorithm versus routine glucose management protocols in intensive care unit patients. Diabetes Care. 2006;29(2):271-6.
43. Doran CV. Modelling and control of hyperglycemia in critical care patients. Masters of Engineering (ME). Christchurch, New Zealand: University of Canterbury; 2004.
44. Wong XW, Singh-Levett I, Hollingsworth LJ, Shaw GM, Hann CE, Lotz T, Lin J, Wong OS, Chase JG. A novel, model-based insulin and nutrition delivery controller for glycemic regulation in critically ill patients. Diabetes Technol Ther. 2006;8(2):174-90.
45. Chase J, Shaw GM, Wong XW, Lotz T, Lin J, Hann CE. Modelbased glycaemic control in critical care: a review of the state of the possible. Biomed Signal Processing Control. 2006;1(1):3-21.
46. Hovorka R, Wilinska ME, Chassin LJ. In Silico simulation environment and glucose control in critically ill subjects: strategic considerations. Third European Medical & Biological Engineering Conference; 2005 Nov. 20-25. Prague, Czech Republic: IFMBE; 2005.
47. Wilinska ME, Chassin LJ, Hovorka R. Automated glucose control in the ICU: effect of nutritional protocol and measurement error. Conf Proc IEEE Eng Med Biol Soc. 2006;1:67-70.
48. Chase JG, Shaw GM, Lotz T, Le Compte A, Wong J, Lin J, Lonergan T, Willacy M, Hann CE. Model-based insulin and nutrition administration for tight glycaemic control in critical care. Curr Drug Deliv. 2007;4(4):283-96.
49. Wilinska ME, Chassin L, Hovorka R. In silico testing-impact on the progress of the closed loop insulin infusion for critically ill patients project. J Diabetes Sci Technol. 2008;2(3):417-23.
50. Hovorka R, Chassin LJ, Wilinska ME. Virtual type 1 diabetic treated by CSII: model description. WC2003:2003 Aug. 24-29; Sydney, Australia; 2003.
51. Luzio S, Dunseath G, Peter R, Pauvaday V, Owens DR. Comparison of the pharmacokinetics and pharmacodynamics of biphasic insulin aspart and insulin glargine in people with type 2 diabetes. Diabetologia. 2006;49(6):1163-8.
52. Chassin LJ, Wilinska ME, Hovorka R. Evaluation of glucose controllers in virtual environment: methodology and sample application. Artif Intell Med. 2004;32(3):171-81.
53. Lehmann ED. AIDA-A computer-based interactive educational diabetes simulator. Diabetes Educ. 1998;24(3):341-6, 348.
54. Wong J, Chase JG, Hann CE, Lotz TF, Lin J, Le Compte A, Shaw GM. Development of a clinical type 1 diabetes metabolic system model and in silico simulation tool. J Diabetes Sci Technol. 2008;2(3):425-35.
55. Wong J, Chase JG, Hann CE, Lotz TF, Lin J, Le Compte A, Shaw GM. In silico simulation of long-term type 1 diabetes glycemic control treatment outcomes. J Diabetes Sci Technol. 2008;2(3):436-49.
56. Lin J, Lee DS, Chase JG, Hann CE, Lotz T, Wong XW. Stochastic modelling of insulin sensitivity variability in critical care. Biomed Signal Processing Control. 2006;1:229-42.
57. Lin J, Lee D, Chase JG, Shaw GM, Le Compte A, Lotz T, Wong J, Lonergan T, Hann CE. Stochastic modelling of insulin sensitivity and adaptive glycemic control for critical care. Comput Methods Programs Biomed. 2008;89(2):141-52.
58. Shaw GM, Chase JG, Wong J, Lin J, Lotz T, Le Compte AJ, Lonergan TR, Willacy MB, Hann CE. Rethinking glycaemic control in critical illness-from concept to clinical practice change. Crit Care Resusc. 2006;8(2):90-9.
59. Lonergan T, Compte AL, Willacy M, Chase JG, Shaw GM, Hann CE, Lotz T, Lin J, Wong XW. A pilot study of the SPRINT protocol for tight glycemic control in critically ill patients. Diabetes Technol Ther. 2006;8(4):449-62.
60. Chase JG, Shaw G, Le Compte A, Lonergan T, Willacy M, Wong XW, Lin J, Lotz T, Lee D, Hann C. Implementation and evaluation of the SPRINT protocol for tight glycaemic control in critically ill patients: a clinical practice change. Crit Care. 2008;12(2):R49.
61. Limpert E, Stahel WA, Abbt M. Log-normal distributions across the sciences: keys and clues. Bioscience. 2001;51(5):341-52.
62. Chase JG, Shaw GM, Hann CE, Lecompte A, Lonergan T, Willacy M, Wong XW, Lin J, Lotz T. Clinical validation of a modelbased glycaemic control design approach and comparison to other clinical protocols. Conf Proc IEEE Eng Med Biol Soc. 2006;1:59-62.